Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-06-17
1993-01-05
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548251, A61K 3141
Patent
active
051770920
ABSTRACT:
Azole compounds including azoles and azolium salts, and their use as transglutaminase inhibitors are disclosed.
REFERENCES:
patent: 4372953 (1983-02-01), Uchida et al.
Berge et al., J. of Pharm. Sciences, 66(1), pp. 1-19 (1977).
Chem. Abstracts, vol. 78, 111222 (1973); Alper et al., J. Het. Chem., 10(1), pp. 5-10 (1973).
Chem. Abstracts, vol. 85, 21219 (1976); Lippman et al., T. Chem. 15(9), pp. 351-352 (1975).
Baldwin John J.
Claremon David A.
King Stella W.
Remy David C.
Dentz Bernard
Merck & Co. , Inc.
Robertson Alice O.
Speer Raymond M.
LandOfFree
Medicinal use of certain tetrazolium salts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicinal use of certain tetrazolium salts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal use of certain tetrazolium salts will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2390774